Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Income Taxes (Details) - Schedule of components of company's deferred tax assets and liabilities

v3.25.4
Income Taxes (Details) - Schedule of components of company's deferred tax assets and liabilities - USD ($)
Dec. 31, 2025
Dec. 31, 2024
Deferred tax assets    
Tax losses carry forwards $ 786,379,000 $ 755,431,000
Inventory related 2,731,000 2,500,000
Intangible assets 4,551,000 11,465,000
Provision for employee related obligations 2,808,000 2,380,000
Stock-based compensation 14,726,000 9,838,000
Deferred revenue 5,386,000 4,524,000
Property, plant and equipment 202,000 254,000
Allowance for credit losses 387,000 173,000
Research and development credit carry forwards 22,511,000 21,577,000
Research and development capitalization (including Section 174) 32,673,000 22,952,000
Deferred Tax Assets, Equity Method Investments 19,349,000 9,240,000
Deferred tax assets (under "Other non-current assets") 9,622,000 6,491,000
Gross deferred tax assets 901,325,000 846,825,000
Valuation allowance (890,920,000) (826,870,000)
Total deferred tax assets 10,405,000 19,955,000
Deferred tax liabilities    
Intangibles assets (8,650,000) (7,423,000)
Property, plant and equipment (1,174,000) (12,077,000)
Total deferred tax liabilities (9,824,000) (19,500,000)
Net deferred tax assets (liabilities) $ 581,000 $ 455,000